The strategies to cure cancer patients by eradicating cancer stem-like cells
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
The strategies to cure cancer patients by eradicating cancer stem-like cells
Authors
Keywords
-
Journal
Molecular Cancer
Volume 22, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2023-10-18
DOI
10.1186/s12943-023-01867-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Combined all‐trans retinoic acid with low‐dose apatinib in treatment of recurrent/metastatic head and neck adenoid cystic carcinoma: A single‐center, secondary analysis of a phase II study
- (2023) Lulu Ye et al. Cancer Medicine
- Cancer stem cell in prostate cancer progression, metastasis and therapy resistance
- (2023) Poornima Verma et al. BIOCHIMICA ET BIOPHYSICA ACTA-REVIEWS ON CANCER
- PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer
- (2023) Antonino Glaviano et al. Molecular Cancer
- FIGHT-101, a first-in-human study of potent and selective FGFR 1–3 inhibitor pemigatinib in pan-cancer patients with FGF/FGFR alterations and advanced malignancies
- (2022) V. Subbiah et al. ANNALS OF ONCOLOGY
- Phase I clinical trial of DNA methyltransferase inhibitor decitabine and PARP inhibitor talazoparib combination therapy in relapsed/refractory acute myeloid leukemia
- (2022) Maria R. Baer et al. CLINICAL CANCER RESEARCH
- A Phase Ib/II Randomized Study of RO4929097, a Gamma Secretase or Notch Inhibitor with or without Vismodegib, a Hedgehog Inhibitor, in Advanced Sarcoma
- (2022) Mrinal M. Gounder et al. CLINICAL CANCER RESEARCH
- Pembrolizumab plus azacitidine in patients with chemotherapy refractory metastatic colorectal cancer: a single-arm phase 2 trial and correlative biomarker analysis
- (2022) Chaoyuan Kuang et al. Clinical Epigenetics
- Phase II study of atezolizumab with bevacizumab for non-squamous non-small cell lung cancer with high PD-L1 expression (@Be Study)
- (2022) Takashi Seto et al. Journal for ImmunoTherapy of Cancer
- Endometrial Cancer Stem Cells: Where Do We Stand and Where Should We Go?
- (2022) Constanze Banz-Jansen et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Tiragolumab plus atezolizumab versus placebo plus atezolizumab as a first-line treatment for PD-L1-selected non-small-cell lung cancer (CITYSCAPE): primary and follow-up analyses of a randomised, double-blind, phase 2 study
- (2022) Byoung Chul Cho et al. LANCET ONCOLOGY
- Anticancer Activity of (S)-5-Chloro-3-((3,5-dimethylphenyl)sulfonyl)-N-(1-oxo-1-((pyridin-4-ylmethyl)amino)propan-2-yl)-1H-indole-2-carboxamide (RS4690), a New Dishevelled 1 Inhibitor
- (2022) Antonio Coluccia et al. Cancers
- Human dendritic cells in cancer
- (2022) Egle Kvedaraite et al. Science Immunology
- WNT signaling and cancer stemness
- (2022) Masuko Katoh et al. Essays in Biochemistry
- Phase II study of Disulfiram and Cisplatin in Refractory Germ Cell Tumors. The GCT-SK-006 phase II trial
- (2022) M Mego et al. INVESTIGATIONAL NEW DRUGS
- Phase II Randomized Study of Ramucirumab and Pembrolizumab Versus Standard of Care in Advanced Non–Small-Cell Lung Cancer Previously Treated With Immunotherapy—Lung-MAP S1800A
- (2022) Karen L. Reckamp et al. JOURNAL OF CLINICAL ONCOLOGY
- Galunisertib plus neoadjuvant chemoradiotherapy in patients with locally advanced rectal cancer: a single-arm, phase 2 trial
- (2022) Tomoko Yamazaki et al. LANCET ONCOLOGY
- Drug repurposing—an emerging strategy in cancer therapeutics
- (2022) Khadija Shahab Turabi et al. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY
- Olutasidenib (FT-2102) in patients with relapsed or refractory IDH1-mutant glioma: A multicenter, open-label, phase Ib/II trial
- (2022) Macarena I de la Fuente et al. NEURO-ONCOLOGY
- SHR2554, an EZH2 inhibitor, in relapsed or refractory mature lymphoid neoplasms: a first-in-human, dose-escalation, dose-expansion, and clinical expansion phase 1 trial
- (2022) Yuqin Song et al. Lancet Haematology
- TGF-β signaling in the tumor metabolic microenvironment and targeted therapies
- (2022) Xueke Shi et al. Journal of Hematology & Oncology
- EGFL7 drives the evolution of resistance to EGFR inhibitors in lung cancer by activating NOTCH signaling
- (2022) Yubo Wang et al. Cell Death & Disease
- Tumor‐associated macrophages in liver cancer: From mechanisms to therapy
- (2022) Kun Cheng et al. Cancer Communications
- The role of stem cells in small-cell lung cancer: Evidence from chemoresistance to immunotherapy
- (2022) Wenwen Guo et al. SEMINARS IN CANCER BIOLOGY
- Association of Autologous Tumor Lysate-Loaded Dendritic Cell Vaccination With Extension of Survival Among Patients With Newly Diagnosed and Recurrent Glioblastoma
- (2022) Linda M. Liau et al. JAMA Oncology
- Safety and Immunogenicity of LY3415244, a Bispecific Antibody Against TIM-3 and PD-L1, in Patients With Advanced Solid Tumors
- (2021) Matthew D. Hellmann et al. CLINICAL CANCER RESEARCH
- The WNT/ROR Pathway in Cancer: From Signaling to Therapeutic Intervention
- (2021) Kerstin Menck et al. Cells
- Targeting stemness of cancer stem cells to fight colorectal cancers
- (2021) Lei Du et al. SEMINARS IN CANCER BIOLOGY
- Comprehending the crosstalk between Notch, Wnt and Hedgehog signaling pathways in oral squamous cell carcinoma - clinical implications
- (2021) Anjali P. Patni et al. CELLULAR ONCOLOGY
- A feasibility study of combined epigenetic and vaccine therapy in advanced colorectal cancer with pharmacodynamic endpoint
- (2021) Katherine M. Bever et al. Clinical Epigenetics
- The role of ALDH2 in tumorigenesis and tumor progression: Targeting ALDH2 as a potential cancer treatment
- (2021) Hong Zhang et al. Acta Pharmaceutica Sinica B
- Cancer Stem Cells: Significance in Origin, Pathogenesis and Treatment of Glioblastoma
- (2021) Karina Biserova et al. Cells
- Phase 1 study of single-agent WNT974, a first-in-class Porcupine inhibitor, in patients with advanced solid tumours
- (2021) Jordi Rodon et al. BRITISH JOURNAL OF CANCER
- Rovalpituzumab Tesirine as a Maintenance Therapy After First-Line Platinum-Based Chemotherapy in Patients With Extensive-Stage–SCLC: Results From the Phase 3 MERU Study
- (2021) Melissa L. Johnson et al. Journal of Thoracic Oncology
- Adjuvant and concurrent temozolomide for 1p/19q non-co-deleted anaplastic glioma (CATNON; EORTC study 26053-22054): second interim analysis of a randomised, open-label, phase 3 study
- (2021) Martin J van den Bent et al. LANCET ONCOLOGY
- A vaccine targeting mutant IDH1 in newly diagnosed glioma
- (2021) Michael Platten et al. NATURE
- Porcupine inhibitors: Novel and emerging anti-cancer therapeutics targeting the Wnt signaling pathway
- (2021) Karmani Shah et al. PHARMACOLOGICAL RESEARCH
- A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida)
- (2021) Lori J. Goldstein et al. BREAST CANCER RESEARCH AND TREATMENT
- The plasticity of pancreatic cancer stem cells: implications in therapeutic resistance
- (2021) Kalyani Patil et al. CANCER AND METASTASIS REVIEWS
- Phase II study of tazemetostat for relapsed or refractory B‐cell non‐Hodgkin lymphoma with EZH2 mutation in Japan
- (2021) Koji Izutsu et al. CANCER SCIENCE
- Vorasidenib, a Dual Inhibitor of Mutant IDH1/2, in Recurrent or Progressive Glioma; Results of a First-in-Human Phase I Trial
- (2021) Ingo K. Mellinghoff et al. CLINICAL CANCER RESEARCH
- MHC Class I Deficiency in Solid Tumors and Therapeutic Strategies to Overcome It
- (2021) Elena Shklovskaya et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- First-line nivolumab plus chemotherapy versus chemotherapy alone for advanced gastric, gastro-oesophageal junction, and oesophageal adenocarcinoma (CheckMate 649): a randomised, open-label, phase 3 trial
- (2021) Yelena Y Janjigian et al. LANCET
- Cancer stem cells in hepatocellular carcinoma — from origin to clinical implications
- (2021) Terence Kin-Wah Lee et al. Nature Reviews Gastroenterology & Hepatology
- A phase II trial of all-trans retinoic acid (ATRA) in advanced adenoid cystic carcinoma
- (2021) Glenn J. Hanna et al. ORAL ONCOLOGY
- Cancer stem cells in TNBC
- (2021) Zhan Hua et al. SEMINARS IN CANCER BIOLOGY
- Phase I Study and Pilot Efficacy Analysis of Entinostat, a Novel Histone Deacetylase Inhibitor, in Chinese Postmenopausal Women with Hormone Receptor-Positive Metastatic Breast Cancer
- (2021) Jiani Wang et al. Targeted Oncology
- Autologous Dendritic Cells in Combination With Chemotherapy Restore Responsiveness of T Cells in Breast Cancer Patients: A Single-Arm Phase I/II Trial
- (2021) David A. Bernal-Estévez et al. Frontiers in Immunology
- Functional Implications of the Dynamic Regulation of EpCAM during Epithelial-to-Mesenchymal Transition
- (2021) Taylor C. Brown et al. Biomolecules
- Extracellular matrix and Hippo signaling as therapeutic targets of antifibrotic compounds for uterine fibroids
- (2021) Md Soriful Islam et al. Clinical and Translational Medicine
- Hedgehog transcriptional effector GLI mediates mTOR-Induced PD-L1 expression in gastric cancer organoids
- (2021) Vivien Koh et al. CANCER LETTERS
- Dual PD-1 and CTLA-4 Checkpoint Blockade Using Balstilimab and Zalifrelimab Combination as Second-Line Treatment for Advanced Cervical Cancer: An Open-Label Phase II Study
- (2021) David M. O'Malley et al. JOURNAL OF CLINICAL ONCOLOGY
- Reversing T-cell Exhaustion in Cancer: Lessons Learned from PD-1/PD-L1 Immune Checkpoint Blockade
- (2021) Natalija Budimir et al. Cancer Immunology Research
- Regulatory T Cells and Human Disease
- (2020) Shimon Sakaguchi et al. Annual Review of Immunology
- Hedgehog signaling pathway inhibitors: an updated patent review (2015–present)
- (2020) Deborah Quaglio et al. EXPERT OPINION ON THERAPEUTIC PATENTS
- Checkpoint inhibitor immunotherapy in kidney cancer
- (2020) Wenxin Xu et al. Nature Reviews Urology
- The functional activity of E-cadherin controls tumor cell metastasis at multiple steps
- (2020) Tae-Young Na et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- TNF-α increases breast cancer stem-like cells through up-regulating TAZ expression via the non-canonical NF-κB pathway
- (2020) Wenjing Liu et al. Scientific Reports
- Revisiting the Roles of Pro-Metastatic EpCAM in Cancer
- (2020) M. Aiman Mohtar et al. Biomolecules
- Bintrafusp Alfa, a Bifunctional Fusion Protein Targeting TGF-β and PD-L1, in Second-Line Treatment of Patients With NSCLC: Results From an Expansion Cohort of a Phase 1 Trial
- (2020) Luis Paz-Ares et al. Journal of Thoracic Oncology
- Ivosidenib in IDH1-mutant, chemotherapy-refractory cholangiocarcinoma (ClarIDHy): a multicentre, randomised, double-blind, placebo-controlled, phase 3 study
- (2020) Ghassan K Abou-Alfa et al. LANCET ONCOLOGY
- The current markers of cancer stem cell in oral cancers
- (2020) Elahe Tahmasebi et al. LIFE SCIENCES
- First-in-human study of the PARP/tankyrase inhibitor E7449 in patients with advanced solid tumours and evaluation of a novel drug-response predictor
- (2020) Ruth Plummer et al. BRITISH JOURNAL OF CANCER
- Expression and function of epithelial cell adhesion molecule EpCAM: where are we after 40 years?
- (2020) Olivier Gires et al. CANCER AND METASTASIS REVIEWS
- Phase 1b study of Wnt inhibitor ipafricept (IPA) with gemcitabine and nab-paclitaxel in patients with previously untreated stage IV pancreatic cancer (mPDAC).
- (2020) Efrat Dotan et al. CLINICAL CANCER RESEARCH
- Targeting the CBP/β-Catenin Interaction to Suppress Activation of Cancer-Promoting Pancreatic Stellate Cells
- (2020) Mingtian Che et al. Cancers
- A Review on Notch Signaling and Colorectal Cancer
- (2020) Ashish Tyagi et al. Cells
- Phase 1 study of CWP232291 in patients with relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome
- (2020) Je-Hwan Lee et al. Blood Advances
- Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer
- (2020) Jennifer R. Diamond et al. BREAST CANCER RESEARCH AND TREATMENT
- Cellular and Molecular Mechanisms of Metformin Action
- (2020) Traci E LaMoia et al. ENDOCRINE REVIEWS
- Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance
- (2020) Nuray Erin et al. DRUG RESISTANCE UPDATES
- Targeting the Wnt/β-catenin signaling pathway in cancer
- (2020) Ya Zhang et al. Journal of Hematology & Oncology
- Pembrolizumab in Microsatellite-Instability–High Advanced Colorectal Cancer
- (2020) Thierry André et al. NEW ENGLAND JOURNAL OF MEDICINE
- Gamma Secretase Inhibitors in Cancer: A Current Perspective on Clinical Performance
- (2020) Tyler R. McCaw et al. ONCOLOGIST
- Anti-LRP5/6 VHHs promote differentiation of Wnt-hypersensitive intestinal stem cells
- (2019) Nicola Fenderico et al. Nature Communications
- Targeting PI3K in cancer: mechanisms and advances in clinical trials
- (2019) Jing Yang et al. Molecular Cancer
- Olaparib and α-specific PI3K inhibitor alpelisib for patients with epithelial ovarian cancer: a dose-escalation and dose-expansion phase 1b trial
- (2019) Panagiotis A Konstantinopoulos et al. LANCET ONCOLOGY
- Nanog Signaling Mediates Radioresistance in ALDH-Positive Breast Cancer Cells
- (2019) Mozhgan Dehghan Harati et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Induction of tolerogenic dendritic cells by activated TGF-β/Akt/Smad2 signaling in RIG-I-deficient stemness-high human liver cancer cells
- (2019) Ming Zhong et al. BMC CANCER
- Histone Deacetylase Inhibition with Panobinostat Combined with Intensive Induction Chemotherapy in Older Patients with Acute Myeloid Leukemia: Phase I Study Results
- (2019) Matthew J. Wieduwilt et al. CLINICAL CANCER RESEARCH
- PD-1 blockade in subprimed CD8 cells induces dysfunctional PD-1+CD38hi cells and anti-PD-1 resistance
- (2019) Vivek Verma et al. NATURE IMMUNOLOGY
- ERAP1 promotes Hedgehog-dependent tumorigenesis by controlling USP47-mediated degradation of βTrCP
- (2019) Francesca Bufalieri et al. Nature Communications
- A randomized phase II trial of nab‐paclitaxel and gemcitabine with tarextumab or placebo in patients with untreated metastatic pancreatic cancer
- (2019) Zishuo Ian Hu et al. Cancer Medicine
- Metformin Regulates the Expression of CD133 Through the AMPK-CEBPβ Pathway in Hepatocellular Carcinoma Cell Lines
- (2019) Osamu Maehara et al. NEOPLASIA
- Phase I trial of belinostat in combination with 13-cis-retinoic acid in advanced solid tumor malignancies: a California Cancer Consortium NCI/CTEP sponsored trial
- (2019) Thehang Luu et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Phase 1 study of the novel enhancer of zeste homolog 2 (EZH2) inhibitor GSK2816126 in patients with advanced hematological and solid tumors
- (2019) Timothy A. Yap et al. CLINICAL CANCER RESEARCH
- Inhibitory effect on ovarian cancer ALDH+ stem-like cells by Disulfiram and Copper treatment through ALDH and ROS modulation
- (2019) Fang Guo et al. BIOMEDICINE & PHARMACOTHERAPY
- Therapeutic Strategies Targeting Cancer Stem Cells and Their Microenvironment
- (2019) Hao-Ran Sun et al. Frontiers in Oncology
- ADAM proteases: Emerging role and targeting of the non-catalytic domains
- (2019) Nayanendu Saha et al. CANCER LETTERS
- Targeting signalling pathways and the immune microenvironment of cancer stem cells — a clinical update
- (2019) Joseph A. Clara et al. Nature Reviews Clinical Oncology
- Wnt Signaling and Its Significance Within the Tumor Microenvironment: Novel Therapeutic Insights
- (2019) Sonal Patel et al. Frontiers in Immunology
- A phase I dose-escalation and dose-expansion study of brontictuzumab in subjects with selected solid tumors
- (2018) R Ferrarotto et al. ANNALS OF ONCOLOGY
- A phase I trial of the γ-secretase inhibitor MK-0752 in combination with gemcitabine in patients with pancreatic ductal adenocarcinoma
- (2018) Natalie Cook et al. BRITISH JOURNAL OF CANCER
- Cancer stem cell in breast cancer therapeutic resistance
- (2018) Xupeng Bai et al. CANCER TREATMENT REVIEWS
- STAT3, stem cells, cancer stem cells and p63
- (2018) Michaela Galoczova et al. CELLULAR & MOLECULAR BIOLOGY LETTERS
- Phase I Study of LY2940680, a Smo Antagonist, in Patients with Advanced Cancer Including Treatment-Naïve and Previously Treated Basal Cell Carcinoma
- (2018) Johanna Bendell et al. CLINICAL CANCER RESEARCH
- Phase I Trial of M7824 (MSB0011359C), a Bifunctional Fusion Protein Targeting PD-L1 and TGFβ, in Advanced Solid Tumors
- (2018) Julius Strauss et al. CLINICAL CANCER RESEARCH
- Synergistic inhibition of the Hedgehog pathway by newly designed Smo and Gli antagonists bearing the isoflavone scaffold
- (2018) Simone Berardozzi et al. EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY
- A multi-arm phase I dose escalating study of an oral NOTCH inhibitor BMS-986115 in patients with advanced solid tumours
- (2018) Kyaw L. Aung et al. INVESTIGATIONAL NEW DRUGS
- Effect of Fruquintinib vs Placebo on Overall Survival in Patients With Previously Treated Metastatic Colorectal Cancer
- (2018) Jin Li et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- CD133: beyond a cancer stem cell biomarker
- (2018) Amir Barzegar Behrooz et al. JOURNAL OF DRUG TARGETING
- Targeting the IL-6/JAK/STAT3 signalling axis in cancer
- (2018) Daniel E. Johnson et al. Nature Reviews Clinical Oncology
- A First‐in‐Human Phase I Study of OPB‐111077, a Small‐Molecule STAT3 and Oxidative Phosphorylation Inhibitor, in Patients with Advanced Cancers
- (2018) Anthony Tolcher et al. ONCOLOGIST
- Olmutinib (HM61713) reversed multidrug resistance by inhibiting the activity of ATP-binding cassette subfamily G member 2 in vitro and in vivo
- (2018) Zhiqiang Zhang et al. Acta Pharmaceutica Sinica B
- Notch Signaling in the Tumor Microenvironment
- (2018) Olivier Meurette et al. CANCER CELL
- Itraconazole as a Non-Castrating Treatment for Biochemically Recurrent Prostate Cancer: a Phase 2 Study
- (2018) Mina Lee et al. Clinical Genitourinary Cancer
- High NRF2 level mediates cancer stem cell-like properties of aldehyde dehydrogenase (ALDH)-high ovarian cancer cells: inhibitory role of all-trans retinoic acid in ALDH/NRF2 signaling
- (2018) Donghyeok Kim et al. Cell Death & Disease
- Overcoming the emerging drug resistance of smoothened: an overview of small-molecule SMO antagonists with antiresistance activity
- (2018) Heng Zhang et al. Future Medicinal Chemistry
- A phase 1 dose escalation and expansion study of Tarextumab (OMP-59R5) in patients with solid tumors
- (2018) David C. Smith et al. INVESTIGATIONAL NEW DRUGS
- Cancer stem cells as a therapeutic target in bladder cancer
- (2018) Nazi Aghaalikhani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Ovarian cancer stem cell: A potential therapeutic target for overcoming multidrug resistance
- (2018) Aynaz Mihanfar et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The most reliable surface marker for the identification of colorectal cancer stem-like cells: A systematic review and meta-analysis
- (2018) Mahdi Abbasian et al. JOURNAL OF CELLULAR PHYSIOLOGY
- New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
- (2018) Anushka Dongre et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Constitutive Activation of the Canonical NF-κB Pathway Leads to Bone Marrow Failure and Induction of Erythroid Signature in Hematopoietic Stem Cells
- (2018) Masahiro Marshall Nakagawa et al. Cell Reports
- Hedgehog Signaling in Cancer: A Prospective Therapeutic Target for Eradicating Cancer Stem Cells
- (2018) Ita Novita Sari et al. Cells
- Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
- (2017) Vincent Ribrag et al. HAEMATOLOGICA
- A phase IIa study of HA-irinotecan, formulation of hyaluronic acid and irinotecan targeting CD44 in extensive-stage small cell lung cancer
- (2017) Muhammad Alamgeer et al. INVESTIGATIONAL NEW DRUGS
- Isolation, identification, and characterization of cancer stem cells: A review
- (2017) Mohammad Reza Abbaszadegan et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Vaccination with poly(IC:LC) and peptide-pulsed autologous dendritic cells in patients with pancreatic cancer
- (2017) Shikhar Mehrotra et al. Journal of Hematology & Oncology
- Tremelimumab in combination with ablation in patients with advanced hepatocellular carcinoma
- (2017) Austin G. Duffy et al. JOURNAL OF HEPATOLOGY
- Potential mechanisms of CD133 in cancer stem cells
- (2017) Jae-Woo Jang et al. LIFE SCIENCES
- Macrophages induce EMT to promote invasion of lung cancer cells through the IL-6-mediated COX-2/PGE 2 /β-catenin signalling pathway
- (2017) Dehai Che et al. MOLECULAR IMMUNOLOGY
- EMT and inflammation: inseparable actors of cancer progression
- (2017) Meggy Suarez-Carmona et al. Molecular Oncology
- Phase IB Trial of the Anti-Cancer Stem Cell DLL4-Binding Agent Demcizumab with Pemetrexed and Carboplatin as First-Line Treatment of Metastatic Non-Squamous NSCLC
- (2017) Mark J. McKeage et al. Targeted Oncology
- Safety and efficacy of abexinostat, a pan-histone deacetylase inhibitor, in non-Hodgkin lymphoma and chronic lymphocytic leukemia: results of a phase II study
- (2017) Vincent Ribrag et al. HAEMATOLOGICA
- Epidermal Growth Factor Receptor Cell Proliferation Signaling Pathways
- (2017) et al. Cancers
- EpCAM Intracellular Domain Promotes Porcine Cell Reprogramming by Upregulation of Pluripotent Gene Expression via Beta-catenin Signaling
- (2017) Tong Yu et al. Scientific Reports
- YAP/TAZ at the Roots of Cancer
- (2016) Francesca Zanconato et al. CANCER CELL
- Molecular and Clinical Effects of Notch Inhibition in Glioma Patients: A Phase 0/I Trial
- (2016) R. Xu et al. CLINICAL CANCER RESEARCH
- Interleukin-6: A Critical Cytokine in Cancer Multidrug Resistance
- (2016) Morteza Ghandadi et al. CURRENT PHARMACEUTICAL DESIGN
- A first-in-human phase I study of the oral Notch inhibitor, LY900009, in patients with advanced cancer
- (2016) Shubham Pant et al. EUROPEAN JOURNAL OF CANCER
- IL-6 Secreted from Cancer-Associated Fibroblasts Mediates Chemoresistance in NSCLC by Increasing Epithelial-Mesenchymal Transition Signaling
- (2016) Yasushi Shintani et al. Journal of Thoracic Oncology
- A phase I trial of the Hedgehog inhibitor, sonidegib (LDE225), in combination with etoposide and cisplatin for the initial treatment of extensive stage small cell lung cancer
- (2016) M. Catherine Pietanza et al. LUNG CANCER
- Notch signalling in context
- (2016) Sarah J. Bray NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Pembrolizumab versus Chemotherapy for PD-L1–Positive Non–Small-Cell Lung Cancer
- (2016) Martin Reck et al. NEW ENGLAND JOURNAL OF MEDICINE
- A pilot study of cetuximab and the hedgehog inhibitor IPI-926 in recurrent/metastatic head and neck squamous cell carcinoma
- (2016) Daniel W. Bowles et al. ORAL ONCOLOGY
- Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways
- (2016) Gemma Leon et al. PHARMACOLOGY & THERAPEUTICS
- Present Yourself! By MHC Class I and MHC Class II Molecules
- (2016) Kenneth L. Rock et al. TRENDS IN IMMUNOLOGY
- First-in-human phase I clinical trial of RG7356, an anti-CD44 humanized antibody, in patients with advanced, CD44-expressing solid tumors
- (2016) C. Willemien Menke-van der Houven van Oordt et al. Oncotarget
- Characterization of cervical cancer stem cell-like cells: phenotyping, stemness, and human papilloma virus co-receptor expression
- (2016) Elizabeth Ortiz-Sánchez et al. Oncotarget
- Crosstalk between Wnt/β-Catenin and NF-κB Signaling Pathway during Inflammation
- (2016) Bin Ma et al. Frontiers in Immunology
- The NF-κB Pathway and Cancer Stem Cells
- (2016) Amanda Rinkenbaugh et al. Cells
- Regulation of Tumor Metastasis by Myeloid-Derived Suppressor Cells
- (2015) Thomas Condamine et al. Annual Review of Medicine
- A phase I trial of intravenous catumaxomab: a bispecific monoclonal antibody targeting EpCAM and the T cell coreceptor CD3
- (2015) Morten Mau-Sørensen et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Curcumin inhibits cancer stem cell phenotypes in ex vivo models of colorectal liver metastases, and is clinically safe and tolerable in combination with FOLFOX chemotherapy
- (2015) Mark I. James et al. CANCER LETTERS
- Aldehyde dehydrogenases and cancer stem cells
- (2015) Xia Xu et al. CANCER LETTERS
- A Small-Molecule Antagonist of the -Catenin/TCF4 Interaction Blocks the Self-Renewal of Cancer Stem Cells and Suppresses Tumorigenesis
- (2015) L. Fang et al. CANCER RESEARCH
- Tenascin-C Protects Cancer Stem-like Cells from Immune Surveillance by Arresting T-cell Activation
- (2015) E. Jachetti et al. CANCER RESEARCH
- Control of PD-L1 Expression by Oncogenic Activation of the AKT–mTOR Pathway in Non–Small Cell Lung Cancer
- (2015) Kristin J. Lastwika et al. CANCER RESEARCH
- A Phase I First-in-Human Study of Enoticumab (REGN421), a Fully Human Delta-like Ligand 4 (Dll4) Monoclonal Antibody in Patients with Advanced Solid Tumors
- (2015) E. G. Chiorean et al. CLINICAL CANCER RESEARCH
- Tankyrase Inhibition Blocks Wnt/ -Catenin Pathway and Reverts Resistance to PI3K and AKT Inhibitors in the Treatment of Colorectal Cancer
- (2015) O. Arques et al. CLINICAL CANCER RESEARCH
- Cancer stem cells in oesophageal squamous cell carcinoma: Identification, prognostic and treatment perspectives
- (2015) Farhadul Islam et al. CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY
- Gastric cancer stem cells: evidence, potential markers, and clinical implications
- (2015) Daniel Brungs et al. JOURNAL OF GASTROENTEROLOGY
- AZD9150, a next-generation antisense oligonucleotide inhibitor of STAT3 with early evidence of clinical activity in lymphoma and lung cancer
- (2015) David Hong et al. Science Translational Medicine
- Afatinib Enhances the Efficacy of Conventional Chemotherapeutic Agents by Eradicating Cancer Stem-like Cells
- (2014) X.-k. Wang et al. CANCER RESEARCH
- A Phase I Study of PF-04449913, an Oral Hedgehog Inhibitor, in Patients with Advanced Solid Tumors
- (2014) A. J. Wagner et al. CLINICAL CANCER RESEARCH
- Phase I Dose-Escalation Trial of the Oral Investigational Hedgehog Signaling Pathway Inhibitor TAK-441 in Patients with Advanced Solid Tumors
- (2014) J. Goldman et al. CLINICAL CANCER RESEARCH
- A Phase I/II, Multiple-Dose, Dose-Escalation Study of Siltuximab, an Anti-Interleukin-6 Monoclonal Antibody, in Patients with Advanced Solid Tumors
- (2014) E. Angevin et al. CLINICAL CANCER RESEARCH
- Phase 2 Trial of Paclitaxel, 13-cis Retinoic Acid, and Interferon Alfa-2b in the Treatment of Advanced Stage or Recurrent Cervical Cancer
- (2014) Mihae Song et al. INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER
- Sonic hedgehog–Gli1 signals promote epithelial–mesenchymal transition in ovarian cancer by mediating PI3K/AKT pathway
- (2014) Zhang Ke et al. MEDICAL ONCOLOGY
- Smoothened (SMO) receptor mutations dictate resistance to vismodegib in basal cell carcinoma
- (2014) Sabrina Pricl et al. Molecular Oncology
- Tackling the cancer stem cells — what challenges do they pose?
- (2014) Diwakar R. Pattabiraman et al. NATURE REVIEWS DRUG DISCOVERY
- Signaling mechanisms of the epithelial-mesenchymal transition
- (2014) D. M. Gonzalez et al. Science Signaling
- Cancer stem-like cell: a novel target for nasopharyngeal carcinoma therapy
- (2014) Pingpin Wei et al. Stem Cell Research & Therapy
- A phase 1b study of humanized KS-interleukin-2 (huKS-IL2) immunocytokine with cyclophosphamide in patients with EpCAM-positive advanced solid tumors
- (2013) Joseph P Connor et al. BMC CANCER
- Deadly crosstalk: Notch signaling at the intersection of EMT and cancer stem cells
- (2013) Ingrid Espinoza et al. CANCER LETTERS
- Loss of Androgen Receptor Expression Promotes a Stem-like Cell Phenotype in Prostate Cancer through STAT3 Signaling
- (2013) A. Schroeder et al. CANCER RESEARCH
- Phase I Study of the Hedgehog Pathway Inhibitor IPI-926 in Adult Patients with Solid Tumors
- (2013) A. Jimeno et al. CLINICAL CANCER RESEARCH
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Notch1 Receptor Regulates AKT Protein Activation Loop (Thr308) Dephosphorylation through Modulation of the PP2A Phosphatase in Phosphatase and Tensin Homolog (PTEN)-null T-cell Acute Lymphoblastic Leukemia Cells
- (2013) Eric C. Hales et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Notch activation inhibits AML growth and survival: a potential therapeutic approach
- (2013) Sankaranarayanan Kannan et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Acquisition of epithelial–mesenchymal transition and cancer stem cell phenotypes is associated with activation of the PI3K/Akt/mTOR pathway in prostate cancer radioresistance
- (2013) L Chang et al. Cell Death & Disease
- NF-κB and STAT3 signaling pathways collaboratively link inflammation to cancer
- (2013) Yihui Fan et al. Protein & Cell
- High aldehyde dehydrogenase activity enhances stem cell features in breast cancer cells by activating hypoxia-inducible factor-2α
- (2012) Ran-Ju Kim et al. CANCER LETTERS
- Cancer Stem Cells: Current Status and Evolving Complexities
- (2012) Jane E. Visvader et al. Cell Stem Cell
- Circulating stem cell-like epithelial cell adhesion molecule-positive tumor cells indicate poor prognosis of hepatocellular carcinoma after curative resection
- (2012) Yun-Fan Sun et al. HEPATOLOGY
- Regulation of cell death and autophagy by IKK and NF-κB: critical mechanisms in immune function and cancer
- (2012) Albert S. Baldwin IMMUNOLOGICAL REVIEWS
- Recent advances in cancer stem cell research for cholangiocarcinoma
- (2012) Toshio Kokuryo et al. Journal of Hepato-Biliary-Pancreatic Sciences
- Noncanonical Notch Signaling Modulates Cytokine Responses of Dendritic Cells to Inflammatory Stimuli
- (2012) M. E. Gentle et al. JOURNAL OF IMMUNOLOGY
- The Cancer Stem-Cell Hypothesis: Its Emerging Role in Lung Cancer Biology and Its Relevance for Future Therapy
- (2012) John D. O’Flaherty et al. Journal of Thoracic Oncology
- Tumour micro-environment elicits innate resistance to RAF inhibitors through HGF secretion
- (2012) Ravid Straussman et al. NATURE
- Wnt pathway inhibition via the targeting of Frizzled receptors results in decreased growth and tumorigenicity of human tumors
- (2012) A. Gurney et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Kinetic Responses of -Catenin Specify the Sites of Wnt Control
- (2012) A. R. Hernandez et al. SCIENCE
- Regulation of CD133 by HDAC6 Promotes β-Catenin Signaling to Suppress Cancer Cell Differentiation
- (2012) Anthony B. Mak et al. Cell Reports
- Cancer drug pan-resistance: pumps, cancer stem cells, quiescence, epithelial to mesenchymal transition, blocked cell death pathways, persisters or what?
- (2012) P. Borst Open Biology
- Wnt Inhibitor Screen Reveals Iron Dependence of -Catenin Signaling in Cancers
- (2011) S. Song et al. CANCER RESEARCH
- Notch signaling: simplicity in design, versatility in function
- (2011) E. R. Andersson et al. DEVELOPMENT
- Aldehyde dehydrogenases and cell proliferation
- (2011) G. Muzio et al. FREE RADICAL BIOLOGY AND MEDICINE
- Stem cell gene expression programs influence clinical outcome in human leukemia
- (2011) Kolja Eppert et al. NATURE MEDICINE
- Thyroid cancer stem cells
- (2011) Reigh-Yi Lin Nature Reviews Endocrinology
- Regulation of glioblastoma stem cells by retinoic acid: role for Notch pathway inhibition
- (2011) M Ying et al. ONCOGENE
- NF-κB and STAT3 cooperatively induce IL6 in starved cancer cells
- (2011) S Yoon et al. ONCOGENE
- Normal and neoplastic nonstem cells can spontaneously convert to a stem-like state
- (2011) C. L. Chaffer et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting Hedgehog -- a Cancer Stem Cell Pathway
- (2010) A. A. Merchant et al. CLINICAL CANCER RESEARCH
- Targeting Notch to Target Cancer Stem Cells
- (2010) A. Pannuti et al. CLINICAL CANCER RESEARCH
- Small-molecule inhibition of Wnt signaling through activation of casein kinase 1α
- (2010) Curtis A Thorne et al. Nature Chemical Biology
- EMT, the cytoskeleton, and cancer cell invasion
- (2009) Mahmut Yilmaz et al. CANCER AND METASTASIS REVIEWS
- The Emerging Role of EpCAM in Cancer and Stem Cell Signaling
- (2009) M. Munz et al. CANCER RESEARCH
- TGF-β-induced epithelial to mesenchymal transition
- (2009) Jian Xu et al. CELL RESEARCH
- Human colon cancer epithelial cells harbour active HEDGEHOG-GLI signalling that is essential for tumour growth, recurrence, metastasis and stem cell survival and expansion
- (2009) Frédéric Varnat et al. EMBO Molecular Medicine
- Molecular Mechanisms of IFN-γ to Up-Regulate MHC Class I Antigen Processing and Presentation
- (2009) Fang Zhou INTERNATIONAL REVIEWS OF IMMUNOLOGY
- Hyaluronan-CD44 Interaction with Protein Kinase Cϵ Promotes Oncogenic Signaling by the Stem Cell Marker Nanog and the Production of MicroRNA-21, Leading to Down-regulation of the Tumor Suppressor Protein PDCD4, Anti-apoptosis, and Chemotherapy Resistance in Breast Tumor Cells
- (2009) Lilly Y. W. Bourguignon et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- ELDA: Extreme limiting dilution analysis for comparing depleted and enriched populations in stem cell and other assays
- (2009) Yifang Hu et al. JOURNAL OF IMMUNOLOGICAL METHODS
- Inhibition of the Hedgehog Pathway in Advanced Basal-Cell Carcinoma
- (2009) Daniel D. Von Hoff et al. NEW ENGLAND JOURNAL OF MEDICINE
- Activation of the hedgehog-signaling pathway in human cancer and the clinical implications
- (2009) L Yang et al. ONCOGENE
- Identification of Gastric Cancer Stem Cells Using the Cell Surface Marker CD44
- (2009) Shigeo Takaishi et al. STEM CELLS
- High aldehyde dehydrogenase and expression of cancer stem cell markers selects for breast cancer cells with enhanced malignant and metastatic ability
- (2008) Alysha K. Croker et al. JOURNAL OF CELLULAR AND MOLECULAR MEDICINE
- The role of PTEN/Akt/PI3K signaling in the maintenance and viability of prostate cancer stem-like cell populations
- (2008) A. Dubrovska et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search